Deals
Becton to Buy C.R. Bard in $24 Billion Medical Supply Deal
- Deal would be the second-biggest in health care this year
- Pressure to bring prices down is leading to consolidation
This article is for subscribers only.
Two of the world’s biggest health-care suppliers plan to combine as Becton, Dickinson & Co. agreed to buy C.R. Bard Inc. for $24 billion, creating a powerhouse that can offer customers everything from syringes to infection-prevention technology.
Becton, Dickinson agreed to pay $317 a share for Bard in cash and stock, or about 25 percent more than Bard’s April 21 closing price, the companies said in a statement on Sunday. Both companies’ boards have unanimously agreed to the deal, according to the release.